Particle accelerator manufacturer for proton therapy, industrial sterilization, and radiopharmaceuticals
IBA manufactures particle accelerator systems across three core markets: proton therapy (oncology), industrial sterilization, and radiopharmaceutical production. The company runs a heavy manufacturing footprint—12 active engineering roles against 5 manufacturing—paired with SAP S/4HANA and Siemens industrial control systems (S7-1500, WinCC), indicating capital-intensive product development and supply-chain complexity. Active adoption of Polarion and Enterprise Architect suggests a shift toward more structured systems engineering and requirements management as product families expand.
IBA is a Belgium-based public company and certified B Corporation with ~2,000 employees worldwide, operating in medical equipment manufacturing and industrial applications. The core business spans proton therapy (radiation oncology), industrial sterilization (electron beam irradiation), radiopharmaceutical solutions, and dosimetry systems. Active hiring across Belgium, United States, China, and Germany reflects geographic expansion, particularly into electron beam and alternative sterilization modalities. Current projects address market penetration in China, regulatory compliance for emerging technologies, and internal automation of financial and HR processes.
IBA runs Salesforce, SAP S/4HANA, and SAP SuccessFactors for business operations, paired with Siemens industrial control systems (S7-1500, WinCC, PROFINET) and design tools (SolidWorks, CATIA, NX) for manufacturing. Python and data analytics round out the stack.
Active projects include expanding electron beam and irradiation technology in China, regulatory compliance and advocacy for new modalities, automating financial and HR processes, and scaling product attributes for integrated solutions. Sales growth in new territories and meeting demand for alternative sterilization methods are key operational priorities.
Other companies in the same industry, closest in size